Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results

Bulletin Express

03/10

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.

The current Board configuration is as follows: • Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong • Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing

The company released the meeting notice on 10 March 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1123900438"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123900438\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123900438?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123900438","market":"us","top_or_hot":-1,"title":"Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results","media":"Bulletin Express","content":"<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.</p>\n<p>The current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing</p>\n<p>The company released the meeting notice on 10 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.</p>\n<p>The current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing</p>\n<p>The company released the meeting notice on 10 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白云山","start_time":0,"source_url":"","article_id":"1123900438","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123900438","pubTimestamp":1773132196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00874":"白云山"},"translate_title":"白云山药业(00874)定于2026年3月20日召开董事会批准2025财年经审核业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00874":1},"content_text":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.\nThe current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing\nThe company released the meeting notice on 10 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}